MERCK KGAA O.N. overview

EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition 10-Feb-2025 / 20:06 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Darmstadt, February 10, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms advanced...

EQS-Ad-hoc: Merck KGaA / Key word(s): Half Year Results Merck KGaA: Strong 2nd Quarter, Guidance raised 26-Jul-2024 / 18:50 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Darmstadt, July 26, 2024: Based on a very strong second quarter of 2024 with net sales of EUR 5.352 bn resulting in an EBITDA pre 1 of EUR 1.509 bn...

EQS-Ad-hoc: Merck KGaA / Key word(s): Study results Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued 24-Jun-2024 / 19:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014 Merck KGaA: Phase...

EQS-Ad-hoc: Merck KGaA / Key word(s): Study results Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide 05-Dec-2023 / 21:34 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Darmstadt, 5...

The $39-million investment is the largest investment the company has made in its semiconductor equipment and services business. Opening of the new factory is part of the company's strategy to expand its global manufacturing capacity and further support the growing presence of key industry players in the state of Arizona. EMD Electronics implements a strategic workforce plan that includes working with key educational institutions and veteran recruitment efforts. CHANDLER, AZ / ACCESSWIRE /...

New silicon dielectrics processed via low-temperature Plasma Enhanced - Atomic Layer Deposition (ALD) technology enables flexible OLEDs in superior display devices. Provides highly improved barrier characteristics: 100 times more effective and 20 times thinner than existing solutions. Wins Display Component of the Year 2023 Award from Society for Information Display (SID). TEMPE, AZ / ACCESSWIRE / May 30, 2023 / EMD Electronics, the U.S. and Canada Electronics business of Merck KGaA, Darmstadt,...

The 16-year renewable energy contract is for the Liberty County Solar project in Texas and is expected to be operational in 2024, propelling Merck KGaA, Darmstadt, Germany, to 90% purchased renewable electricity in the U.S. TEMPE, AZ / ACCESSWIRE / May 15, 2023 / EMD Electronics, the U.S. and Canada electronics business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a major step towards executing its sustainability strategy. The company signed a...